https://www.mlo-online.com/management/news/55405898/cap-announces-most-recent-cancer-protocol-updatesMLO Onlineen2026-09-17T15:47:20.000ZCAP announces most recent cancer protocol updateshttps://www.mlo-online.com/disease/cancer/news/55405892/nccn-publishes-personalized-treatment-guide-for-older-adults-with-cancerMLO Onlineen2026-09-17T15:42:21.000ZNCCN publishes personalized treatment guide for older adults with cancerhttps://www.mlo-online.com/molecular/news/55405887/mayo-clinic-and-thermo-fisher-scientific-launch-precure-llc-to-uncover-early-disease-signalsMLO Onlineen2026-09-17T15:39:19.000ZMayo Clinic and Thermo Fisher Scientific launch Precure, LLC to uncover early disease signalshttps://www.mlo-online.com/management/regulatory/news/55405523/adlm-offers-recommendations-for-modernizing-clia-regulationsMLO Onlineen2026-09-16T15:50:05.000ZADLM offers recommendations for modernizing CLIA regulationshttps://www.mlo-online.com/disease/analyzers/news/55405516/new-cn-3000-and-cn-6000-hemostasis-testing-systems-now-available-in-usMLO Onlineen2026-09-16T15:43:07.000ZNew CN-3000 and CN-6000 hemostasis testing systems now available in U.S.https://www.mlo-online.com/molecular/news/55405508/thermo-fisher-scientific-launches-advanced-orbitrap-isora-mass-spectrometers-for-molecular-level-isotope-analysisMLO Onlineen2026-09-16T15:31:29.000ZThermo Fisher Scientific launches advanced Orbitrap Isora mass spectrometers for molecular-level isotope analysis